ImageneBio (IMA) Depreciation & Amortization (CF) (2020 - 2025)

ImageneBio has disclosed Depreciation & Amortization (CF) across 6 years of filings, most recently posting $87000.0 for Q2 2025.

• Depreciation & Amortization (CF) for Q2 2025 came in at $87000.0, down 5.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $89000.0 (down 91.77% YoY), and the FY2024 annual result was $1.8 million, up 80.0% from the prior year.
• Depreciation & Amortization (CF) came in at $87000.0 for Q2 2025 at ImageneBio, up from $2000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $681000.0 in Q4 2024 to a low of $2000.0 in Q1 2025.
• The 5-year median for Depreciation & Amortization (CF) is $171500.0 (2021), against an average of $188055.6.
• Across the five-year window, Depreciation & Amortization (CF) jumped 138.95% in 2024 and slumped 99.09% in 2025, its largest moves.
• ImageneBio's Depreciation & Amortization (CF) stood at $163000.0 in 2021, then advanced by 28.83% to $210000.0 in 2022, then surged by 35.71% to $285000.0 in 2023, then surged by 138.95% to $681000.0 in 2024, then slumped by 87.22% to $87000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $87000.0 (Q2 2025), $2000.0 (Q1 2025), and $681000.0 (Q4 2024), per Business Quant data.